DHR
NYSE · Life Sciences Tools & Services
Danaher Corp
$189.60
+5.71 (+3.11%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Price Target
Analyst Price Target
-16.6% upside
Low Target
$107.89
Average Target
$158.11
High Target
$252.83
Current Price
$189.60
Current
$189.60
$189.60
Target
$158.11
$158.11
$107.89
$158.11 avg
$252.83
Scenario Analysis
Bear Case
$107.89
-43.1%
Low target
Base Case
$158.11
-16.6%
Avg target
Bull Case
$252.83
+33.3%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$242.80
-21.9% from high
52-Week Low
$171.00
+10.9% from low
50-Day SMA
$227.23
-16.6% vs SMA
200-Day SMA
$209.48
-9.5% vs SMA
RSI (14)
39.9
Neutral
Target vs 52W High
$158.11
-34.9% vs high
Next Earnings Report
Apr 21, 2026 · Before Market Open
19d
until earnings
EPS Est: $1.96
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 88% | $369.21 | -24.9% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -16.6% |
| A | Buy | 29 | 72% | $64.69 | -43.2% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -51.4% |
| MTD | Hold | 21 | 43% | $170.43 | -86.5% |
| ILMN | Hold | 28 | 54% | $169.36 | +37.4% |
| WAT | Buy | 28 | 57% | $189.60 | -36.3% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.6% |